Please login to the form below

Not currently logged in
Email:
Password:

AZ to outsource drug manufacturing

AstraZeneca will outsource its drug manufacturing operations over the next 10 years, according to a report in The Times

According to a 17 September report in the UK newspaper The Times, the UK's second-largest pharmaceutical company AstraZeneca (AZ) has said it will outsource its drug manufacturing operations over the next 10 years.

In an interview with The Times, AZ's executive vice-president of operations, David Smith, said: "Manufacturing for AstraZeneca is not a core activity. AstraZeneca is about innovation and brand-building ... There are lots of people and organisations that can manufacture better than we can."

Smith is heading up a restructuring move which will cut costs and augment profits in anticipation of a number of high-profile patent expiries of a number of AZ's top-selling products.

He added that the company will reposition itself as a pure research, development and marketing concern.

The company's priority, according to Smith is to outsource all manufacturing of active pharmaceutical ingredients (API), which are the basic chemicals used in the formulation of ethical medicines, says the times.

In July 2007, AZ and IBM signed a USD 1.4bn, seven-year global strategic IT outsourcing agreement.

The deal renewed and expanded on the scope of an existing contract and covered the provision of IT infrastructure services to 60 countries. It included services to additional functions within AZ.

IBM will provide a single global technical infrastructure, managing IT services for AZ across its global organisation. The deal includes server and storage hosting, service desks, PC management, network and communications services, including e-mail, and computer operations support.

AZ will retain control of its overall IT strategy and the development and support of its application systems.

17th September 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics